These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6396561)

  • 1. [Phase II study of the treatment of CML blast crisis with vindesine and prednisone].
    Jehn U; Mezger J
    Onkologie; 1984 Dec; 7(6):342-5. PubMed ID: 6396561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic myeloid leukemia blast crisis with vindesine and prednisone.
    Jehn U; Mezger J
    Cancer Treat Rep; 1985 Apr; 69(4):445-8. PubMed ID: 3857971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of vindesine and prednisone in malignant lymphoma and acute leukemia.
    Raich PC; Walker BK; Rogers JS; Subramanian VP; Fontana JA; Knost JA; Denning B
    Cancer Treat Rep; 1983 May; 67(5):485-7. PubMed ID: 6573959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vindesine-prednisone in the treatment of blast crisis of chronic myeloid leukemia.
    Lemoine F; Najman A; Laporte JP; Gorin NC; Duhamel G
    Cancer Treat Rep; 1985 Feb; 69(2):203-4. PubMed ID: 3855698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of the blast crisis in chronic myeloid leukemia. Results of a phase II study with vindesine].
    Hellriegel KP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):699-706. PubMed ID: 6172337
    [No Abstract]   [Full Text] [Related]  

  • 6. [A randomized controlled study on vindesine and vincristine in combination with prednisolone in the treatment of adult acute lymphocytic leukemia and blastic crisis of chronic myeloid leukemia].
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2500-8. PubMed ID: 6580840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Administration of vindesine sulfate for the treatment of malignant hematological tumors].
    Ueda T; Masaoka T; Shibata H; Kubota Y; Saigo K; Kusakabe H; Takubo T; Nakamura H; Yoshitake J; Ishigami S
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):306-15. PubMed ID: 6764103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse.
    Garay G; Milone J; Dibar E; Pavlovsky S; Kvicala R; Sackmann Muriel F; Montres Varela D; Eppinger-Helft M
    Cancer Chemother Pharmacol; 1983; 10(3):224-6. PubMed ID: 6345018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vindesine effect in myeloid leukemia.
    Baccarani M; Zaccaria A; Corbelli G; Tura S
    Cancer Chemother Pharmacol; 1982; 8(3):255-9. PubMed ID: 6957273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy of chronic myelogenous leukemia in blastic crisis--vindesine, cytosine arabinoside prednisolone combination therapy].
    Uzuka Y; Saito Y; Takahash H; Komatsu M
    Gan To Kagaku Ryoho; 1984 May; 11(5):1064-70. PubMed ID: 6586112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of vindesine in patients with hematological malignancies.
    Hulhoven R; Michaux JL; Cornu G; Ferránt A; Bosly A; Delannoy A; Sokal G
    Biomedicine; 1980 Apr; 33(2):31-2. PubMed ID: 6931617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of the blastic crisis of chronic myelogenous leukemia with the combination of vindesine and prednisolone, and cytosine arabinoside.
    Uzuka Y; Saito Y
    Tohoku J Exp Med; 1983 Apr; 139(4):419-20. PubMed ID: 6575487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phase II study of vindesine in hematological malignancies].
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2509-15. PubMed ID: 6580841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphoid blast crisis in chronic myelogenous leukemia].
    Ranft K
    Dtsch Med Wochenschr; 1984 Jan; 109(1):20-3. PubMed ID: 6581956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vindesine and prednisone for remission induction in children with acute lymphocytic leukemia.
    Vats TS; Mehta P; Trueworthy RC; Smith SD; Klopovich P
    Cancer; 1981 Jun; 47(12):2789-92. PubMed ID: 6942907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vindesine in the treatment of refractory hematologic malignancies: a phase II study.
    Mandelli F; Amadori S; Giona F; Antonietta M; Spiriti A; Pastore S; Meloni G; Paolucci G
    Leuk Res; 1982; 6(5):649-52. PubMed ID: 7154707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phase II study of Vindesine in patients with hematological malignancy].
    Sampi K; Honda T; Hayashi Y; Hattori M
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1536-7. PubMed ID: 6347082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas.
    Bayssas M; Gouveia J; Ribaud P; Musset M; de Vassal F; Pico JL; de Luca L; Misset JL; Machover D; Belpomme D; Schwarzenberg L; Jasmin C; Hayat M; Mathé G
    Cancer Chemother Pharmacol; 1979; 2(4):247-55. PubMed ID: 287569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vindesine for metastatic malignant melanoma. A phase II trial.
    Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of chronic myelogenous leukemia in blastic crisis with the chemotherapy incorporating vindesine-prednisolone.
    Saito Y; Uzuka Y; Takahashi H; Komatsu M; Ito T
    Tohoku J Exp Med; 1986 Jan; 148(1):65-72. PubMed ID: 3458333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.